Cargando…

Development and Validation of a Novel 8 Immune Gene Prognostic Signature Based on the Immune Expression Profile for Hepatocellular Carcinoma

BACKGROUND: The immune microenvironment plays a vital role in the development of hepatocellular carcinoma (HCC). This study explored novel immune-related biomarkers to predict the prognosis of patients with HCC. METHODS: RNA-Seq data were downloaded from The Cancer Genome Atlas (TCGA). Univariate Co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Dafeng, Wang, Yu, Zhou, Kailun, Wu, Jincai, Zhang, Zhensheng, Zhang, Jiachao, Yu, Zhiwei, Liu, Luzheng, Liu, Xiangmei, Li, Bidan, Zheng, Jinfang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7439501/ https://www.ncbi.nlm.nih.gov/pubmed/32884295 http://dx.doi.org/10.2147/OTT.S263047

Ejemplares similares

Identification of an extracellular vesicle-related gene signature in the prediction of pancreatic cancer clinical prognosis
por: Xu, Dafeng, et al.
Publicado: (2020)

Systematic Characterization of Novel Immune Gene Signatures Predicts Prognostic Factors in Hepatocellular Carcinoma
por: Xu, Dafeng, et al.
Publicado: (2021)

Identification and clinical validation of EMT-associated prognostic features based on hepatocellular carcinoma
por: Xu, Dafeng, et al.
Publicado: (2021)

Systematic Analysis of an Invasion-Related 3-Gene Signature and Its Validation as a Prognostic Model for Pancreatic Cancer
por: Xu, Dafeng, et al.
Publicado: (2021)

Identification and Validation of an Immune-related Prognostic Signature for Hepatocellular Carcinoma
por: Xia, Xinxin, et al.
Publicado: (2021)

Identification and Validation of an Immune-Related eRNA Prognostic Signature for Hepatocellular Carcinoma
por: Cai, Shenglan, et al.
Publicado: (2021)

ECT2 overexpression promotes the polarization of tumor-associated macrophages in hepatocellular carcinoma via the ECT2/PLK1/PTEN pathway
por: Xu, Dafeng, et al.
Publicado: (2021)

Correction to: ECT2 overexpression promotes the polarization of tumor-associated macrophages in hepatocellular carcinoma via the ECT2/PLK1/PTEN pathway
por: Xu, Dafeng, et al.
Publicado: (2022)

Identification and Validation of Immune-Related Gene Prognostic Signature for Hepatocellular Carcinoma
por: Chen, Wenbiao, et al.
Publicado: (2020)

Identification and validation of redox-immune based prognostic signature for hepatocellular carcinoma
por: Tu, Kangsheng, et al.
Publicado: (2021)

Development and validation of an ECM-related prognostic signature to predict the immune landscape of human hepatocellular carcinoma
por: Wu, Guozhi, et al.
Publicado: (2022)

Establishment and Validation of a Prognostic Immune Signature in Neuroblastoma
por: Yu, Yunhu, et al.
Publicado: (2021)

Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma
por: Peng, Yanan, et al.
Publicado: (2021)

Construction and validation of an immunity-related prognostic signature for breast cancer
por: Zhu, Tao, et al.
Publicado: (2020)

Establishment and Validation of a Peroxisome-related Gene Signature for Prognostic Prediction and Immune Distinction in Hepatocellular Carcinoma
por: Miao, Dan, et al.
Publicado: (2022)

Identification and Validation of Immune- and Stemness-Related Prognostic Signature of Melanoma
por: Zhang, Yan, et al.
Publicado: (2021)

Identification and analysis of necroptosis-associated signatures for prognostic and immune microenvironment evaluation in hepatocellular carcinoma
por: Lu, Juan, et al.
Publicado: (2022)

Development and validation of an immune‐related prognostic signature in lung adenocarcinoma
por: Sun, Sijin, et al.
Publicado: (2020)

Efferocytosis signatures as prognostic markers for revealing immune landscape and predicting immunotherapy response in hepatocellular carcinoma
por: Xu, Ke, et al.
Publicado: (2023)

Development and validation of an immune gene-set based Prognostic signature in ovarian cancer
por: Shen, Sipeng, et al.
Publicado: (2018)

Development and Validation of a Combined Ferroptosis and Immune Prognostic Classifier for Hepatocellular Carcinoma
por: Liu, Yang, et al.
Publicado: (2020)

Development and validation of an immune gene-set based prognostic signature for soft tissue sarcoma
por: Shen, Rui, et al.
Publicado: (2021)

Development and validation of a novel cellular senescence-related prognostic signature for predicting the survival and immune landscape in hepatocellular carcinoma
por: Sun, Rui, et al.
Publicado: (2022)

Development and validation of a robust immune-related risk signature for hepatocellular carcinoma
por: Liu, Zaoqu, et al.
Publicado: (2021)

Constructing and validating of m7G-related genes prognostic signature for hepatocellular carcinoma and immune infiltration: potential biomarkers for predicting the overall survival
por: Liu, Pulin, et al.
Publicado: (2022)

Identification and validation of immune‐related lncRNA prognostic signatures for melanoma
por: Xiao, Bo, et al.
Publicado: (2021)

Identification of immune landscape signatures associated with clinical and prognostic features of hepatocellular carcinoma
por: Yan, Hongmei, et al.
Publicado: (2020)

Identification of an Immune-Related Prognostic Signature Associated With Immune Infiltration in Melanoma
por: Liu, Nian, et al.
Publicado: (2020)

Identification and validation of a hypoxia-related prognostic and immune microenvironment signature in bladder cancer
por: Sun, Xianchao, et al.
Publicado: (2021)

Construction and Validation of an Immune Cell Signature Score to Evaluate Prognosis and Therapeutic Efficacy in Hepatocellular Carcinoma
por: Xu, Linfeng, et al.
Publicado: (2021)

Survival prediction and response to immune checkpoint inhibitors: A prognostic immune signature for hepatocellular carcinoma
por: Xu, Ying, et al.
Publicado: (2020)

Development and Validation of an Immune-Related Prognostic Signature in Cervical Cancer
por: Su, Rongjia, et al.
Publicado: (2022)

HSPB11 is a Prognostic Biomarker Associated with Immune Infiltrates in Hepatocellular Carcinoma
por: Liu, Hui, et al.
Publicado: (2022)

A novel cuproptosis-related immune checkpoint gene signature identification and experimental validation in hepatocellular carcinoma
por: Xie, Yusai, et al.
Publicado: (2022)

Systematic Construction and Validation of a Prognostic Model for Hepatocellular Carcinoma Based on Immune-Related Genes
por: Yu, Jiahao, et al.
Publicado: (2021)

Development and Validation of a Prognostic Signature Based on Immune Genes in Cervical Cancer
por: Chen, Yu, et al.
Publicado: (2021)

Development and validation of an immune‐related prognosis signature associated with hypoxia and ferroptosis in hepatocellular carcinoma
por: Yang, Chun‐Bo, et al.
Publicado: (2022)

Prognostic Signature and Tumor Immune Landscape of N7-Methylguanosine-Related lncRNAs in Hepatocellular Carcinoma
por: Wei, Wei, et al.
Publicado: (2022)

Development and Validation of a Hypoxia-Associated Prognostic Signature Related to Osteosarcoma Metastasis and Immune Infiltration
por: Fu, Yucheng, et al.
Publicado: (2021)

Development and Verification of a Combined Immune- and Metabolism-Related Prognostic Signature for Hepatocellular Carcinoma
por: Guo, Yuanyuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8f8op29sfb0d9190c77772l61o